Alpha Cancer Technologies Inc. (ACT) is a private clinical stage biotechnology company with platform technologies in Immunotherapy and Immuno-Oncology. These platforms under development treat auto-immune disease indications and cancer. The company’s drug products use our proprietary recombinant human alpha fetoprotein (AFP).
Company Details
- Employees
- 5
- Founded
- 2008
- Address
- Mars Center, South Tower, 200-101 College St, Toronto,ontario M5g 1l7,canada
- Phone
- 416-826-6626
- is****@****cer.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- alpha-cancer.com
- HQ
- Toronto, Ontario
Alpha Cancer Technologies Inc. Questions
Alpha Cancer Technologies Inc.'s helpline number is 416-826-6626
Alpha Cancer Technologies Inc.'s website is alpha-cancer.com
Alpha Cancer Technologies Inc.'s LinkedIn profile is https://ca.linkedin.com/company/alpha-cancer-technologies-inc.
Alpha Cancer Technologies Inc. has
5 employees.
View email and phone details for 5
employees at Alpha Cancer Technologies Inc..
Alpha Cancer Technologies Inc.'s industry is
Biotechnology Research
Alpha Cancer Technologies Inc.'s top competitors are
Antibe Therapeutics Inc.,
Cellectar Biosciences, Inc.,
Form Bio,
Amacathera,
Jn Biosciences Llc,
Alexion Pharmaceuticals, Inc.,
Avicanna Inc. (Tsx:avcn),
A-Alpha Bio,
Beagle Scientific Inc.,
Neuro Medix Inc..
Alpha Cancer Technologies Inc.'s support email address is isherman@alpha-cancer.com
Alpha Cancer Technologies Inc.'s categories are Biotechnology Research
Alpha Cancer Technologies Inc.'s founding year is 2008
